01/02/2025
3:32 PM | HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:34 PM | Davidson Michael H. (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:36 PM | Ede-Golightly James (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:38 PM | Ross Iain (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:39 PM | Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
TOOMAN CRAIG A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:43 PM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
7:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/20/2024
4:32 PM | Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/09/2024
7:12 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2024
3:54 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
8:44 AM | Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:24 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
4:20 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form F-3ASR | |
08/15/2024
8:05 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
5:51 PM | Invus Global Management, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
06/27/2024
6:40 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024
7:38 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
7:41 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
1:21 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
11:15 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form EFFECT | |
05/08/2024
4:14 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form DEL AM | |
05/01/2024
3:37 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024
7:36 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024
6:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024
7:52 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/13/2024
6:10 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2024
7:12 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
8:54 AM | Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:55 AM | Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
5:15 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
4:05 PM | Artal International S.C.A. (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
Free SLN Stock Alerts